Park Ha Biological Technology Co., Ltd. (PHH) - Net Assets
Based on the latest financial reports, Park Ha Biological Technology Co., Ltd. (PHH) has net assets worth $4.25 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.83 Million) and total liabilities ($1.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.25 Million |
| % of Total Assets | 72.88% |
| Annual Growth Rate | -17.07% |
| 5-Year Change | -99.91% |
| 10-Year Change | -99.9% |
| Growth Volatility | 179.87 |
Park Ha Biological Technology Co., Ltd. - Net Assets Trend (1993–2024)
This chart illustrates how Park Ha Biological Technology Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Park Ha Biological Technology Co., Ltd. (1993–2024)
The table below shows the annual net assets of Park Ha Biological Technology Co., Ltd. from 1993 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.51 Million | +48.75% |
| 2023-12-31 | $1.01 Million | +573.74% |
| 2022-12-31 | $150.28K | +125.99% |
| 2021-12-31 | $-578.18K | -100.03% |
| 2017-12-31 | $1.66 Billion | -5.62% |
| 2016-12-31 | $1.76 Billion | -14.00% |
| 2015-12-31 | $2.05 Billion | +30.49% |
| 2014-12-31 | $1.57 Billion | -7.04% |
| 2013-12-31 | $1.69 Billion | +8.19% |
| 2012-12-31 | $1.56 Billion | +6.91% |
| 2011-12-31 | $1.46 Billion | -7.41% |
| 2010-12-31 | $1.58 Billion | +4.92% |
| 2009-12-31 | $1.50 Billion | +18.61% |
| 2008-12-31 | $1.27 Billion | -18.77% |
| 2007-12-31 | $1.56 Billion | +0.97% |
| 2006-12-31 | $1.55 Billion | -52.00% |
| 2005-12-31 | $3.22 Billion | -22.39% |
| 2004-12-31 | $4.15 Billion | +0.61% |
| 2003-12-31 | $4.12 Billion | +43.58% |
| 2002-12-31 | $2.87 Billion | +61.68% |
| 2001-12-31 | $1.78 Billion | -4.97% |
| 2000-12-31 | $1.87 Billion | +14.65% |
| 1999-12-31 | $1.63 Billion | -6.16% |
| 1998-12-31 | $1.74 Billion | +14.77% |
| 1997-12-31 | $1.51 Billion | -66.92% |
| 1995-12-31 | $4.58 Billion | +9.54% |
| 1994-12-31 | $4.18 Billion | +738.68% |
| 1993-12-31 | $498.31 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Park Ha Biological Technology Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 99.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $271.79K | 18.05% |
| Common Stock | $500.00 | 0.03% |
| Other Comprehensive Income | $72.59K | 4.82% |
| Other Components | $1.16 Million | 77.10% |
| Total Equity | $1.51 Million | 100.00% |
Park Ha Biological Technology Co., Ltd. Competitors by Market Cap
The table below lists competitors of Park Ha Biological Technology Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Minrex Resources Ltd
AU:MRR
|
$13.05 Million |
|
MMS Ventures Bhd
KLSE:0113
|
$13.06 Million |
|
Kaanapali Land LLC
PINK:KANP
|
$13.06 Million |
|
Daewoo SBI SPAC 1
KQ:215480
|
$13.08 Million |
|
BSL Limited
NSE:BSL
|
$13.04 Million |
|
Solartron Public Company Limited
BK:SOLAR
|
$13.04 Million |
|
Rackla Metals Inc
PINK:RMETF
|
$13.03 Million |
|
PT Klinko Karya Imaji Tbk
JK:KLIN
|
$13.02 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Park Ha Biological Technology Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,012,473 to 1,506,085, a change of 493,612 (48.8%).
- Net income of 478,561 contributed positively to equity growth.
- New share issuances of 500 increased equity.
- Other comprehensive income increased equity by 116,091.
- Other factors decreased equity by 101,540.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $478.56K | +31.78% |
| Share Issuances | $500.00 | +0.03% |
| Other Comprehensive Income | $116.09K | +7.71% |
| Other Changes | $-101.54K | -6.74% |
| Total Change | $- | 48.75% |
Book Value vs Market Value Analysis
This analysis compares Park Ha Biological Technology Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.70x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.01x to 6.70x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | $28.10 | $0.39 | x |
| 1994-12-31 | $31.27 | $0.39 | x |
| 1995-12-31 | $17.37 | $0.39 | x |
| 1997-12-31 | $15.36 | $0.39 | x |
| 1998-12-31 | $18.56 | $0.39 | x |
| 1999-12-31 | $22.28 | $0.39 | x |
| 2000-12-31 | $29.17 | $0.39 | x |
| 2001-12-31 | $33.44 | $0.39 | x |
| 2002-12-31 | $36.72 | $0.39 | x |
| 2003-12-31 | $39.67 | $0.39 | x |
| 2004-12-31 | $41.02 | $0.39 | x |
| 2005-12-31 | $28.31 | $0.39 | x |
| 2006-12-31 | $27.46 | $0.39 | x |
| 2007-12-31 | $29.31 | $0.39 | x |
| 2008-12-31 | $23.33 | $0.39 | x |
| 2009-12-31 | $27.01 | $0.39 | x |
| 2010-12-31 | $27.82 | $0.39 | x |
| 2011-12-31 | $25.59 | $0.39 | x |
| 2012-12-31 | $24.77 | $0.39 | x |
| 2013-12-31 | $25.30 | $0.39 | x |
| 2014-12-31 | $28.09 | $0.39 | x |
| 2015-12-31 | $23.88 | $0.39 | x |
| 2016-12-31 | $20.36 | $0.39 | x |
| 2017-12-31 | $11.79 | $0.39 | x |
| 2021-12-31 | $-0.02 | $0.39 | x |
| 2022-12-31 | $0.01 | $0.39 | x |
| 2023-12-31 | $0.04 | $0.39 | x |
| 2024-12-31 | $0.06 | $0.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Park Ha Biological Technology Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 31.78%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 20.09%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 2.05x
- Recent ROE (31.78%) is above the historical average (13.27%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 12.96% | 0.00% | -0.03x | 9.57x | $14.73 Million |
| 1994 | 13.27% | 0.00% | -0.03x | 9.33x | $17.67 Million |
| 1995 | 13.41% | 0.00% | -0.04x | 9.32x | $20.77 Million |
| 1997 | -5.89% | 0.00% | 0.00x | 9.15x | $-129.66 Million |
| 1998 | 28.39% | 0.00% | 0.00x | 9.16x | $181.39 Million |
| 1999 | 91.81% | 0.00% | 0.00x | 3.62x | $968.60 Million |
| 2000 | 11.81% | 16.02% | 0.26x | 2.85x | $28.00 Million |
| 2001 | 12.77% | 8.81% | 0.27x | 5.40x | $49.30 Million |
| 2002 | 5.02% | 4.00% | 0.24x | 5.17x | $-97.10 Million |
| 2003 | 13.47% | 15.82% | 0.16x | 5.46x | $73.20 Million |
| 2004 | 8.42% | 10.69% | 0.15x | 5.33x | $-34.10 Million |
| 2005 | 4.73% | 3.09% | 0.23x | 6.55x | $-80.10 Million |
| 2006 | -1.06% | -0.76% | 0.19x | 7.10x | $-167.50 Million |
| 2007 | -0.78% | -0.49% | 0.26x | 6.12x | $-164.90 Million |
| 2008 | -20.06% | -68.83% | 0.04x | 6.53x | $-380.60 Million |
| 2009 | 10.25% | 5.68% | 0.33x | 5.44x | $3.80 Million |
| 2010 | 3.07% | 1.74% | 0.25x | 7.21x | $-108.40 Million |
| 2011 | -8.81% | -5.74% | 0.23x | 6.78x | $-271.20 Million |
| 2012 | 2.23% | 1.24% | 0.29x | 6.29x | $-118.60 Million |
| 2013 | 8.10% | 4.75% | 0.32x | 5.31x | $-31.60 Million |
| 2014 | -11.97% | -28.95% | 0.15x | 2.78x | $-339.50 Million |
| 2015 | -9.94% | -16.58% | 0.22x | 2.77x | $-262.80 Million |
| 2016 | -17.67% | -31.03% | 0.20x | 2.91x | $-302.20 Million |
| 2017 | -35.08% | -42.54% | 0.25x | 3.27x | $-249.30 Million |
| 2021 | 0.00% | -52.09% | 1.57x | 0.00x | $-427.18K |
| 2022 | 127.30% | 9.97% | 0.76x | 16.76x | $176.27K |
| 2023 | 84.15% | 34.65% | 1.09x | 2.24x | $750.79K |
| 2024 | 31.78% | 20.09% | 0.77x | 2.05x | $327.95K |
Industry Comparison
This section compares Park Ha Biological Technology Co., Ltd.'s net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,902,292,270
- Average return on equity (ROE) among peers: 16.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Park Ha Biological Technology Co., Ltd. (PHH) | $4.25 Million | 12.96% | 0.37x | $13.04 Million |
| Acme United Corporation (ACU) | $20.60 Million | 6.31% | 1.00x | $170.65 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $2.46 Billion | 23.05% | 0.81x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.65 Billion | 15.91% | 0.47x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $10.38 Billion | 3.13% | 0.16x | $1.01 Billion |
| Bemax Inc (BMXC) | $-586.49K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-1.40 Million | 0.00% | 0.00x | $10.10K |
| Church & Dwight Company Inc (CHD) | $1.98 Billion | 23.21% | 1.20x | $22.59 Billion |
| Colgate-Palmolive Company (CL) | $2.54 Billion | 95.67% | 4.01x | $67.98 Billion |
| CleanGo Innovations Inc (CLGOF) | $-1.20 Million | 0.00% | 0.00x | $437.05K |
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more